Tech Company Financing Transactions
Samsara Therapeutics Funding Round
On 2/27/2019, Samsara Therapeutics received Seed funding from Apollo Ventures and private investors.
Transaction Overview
Company Name
Announced On
2/27/2019
Transaction Type
Venture Equity
Amount
Unknown
Round
Seed
Investors
Apollo Ventures (Lead Investor) (James Peyer)
Proceeds Purpose
The company plans to use the proceeds from the seed financing to advance its existing pipeline of therapeutic candidates, as well as continue the identification of new candidates through proprietary phenotypic screening of curated chemical libraries.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Grosse Reichenstrasse 27
Hamburg, 20457
Germany
Hamburg, 20457
Germany
Phone
Undisclosed
Website
Email Address
Overview
Samsara Therapeutics Inc. is a platform company engaged in the discovery and development of compounds that address the primary molecular causes of disease initiation and progression. It was built around the world's largest and most technically sophisticated drug screening platform that was designed specifically to identify new molecules that extend healthy lifespan.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jens Eckstein
Chief Medical Officer
Warren Galloway
Chief Scientific Officer
Peter Hamley
Founder
Sebastian Aguiar
Browse more venture capital transactions:
Prev: 2/27/2019: CMD venture capital transaction
Next: 2/27/2019: Sapling venture capital transaction
Share this article
About Our VC Transactions Data
We record tech company VC transactions. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs